Ultragenyx Pharmaceutical
RARE
RARE
238 hedge funds and large institutions have $4.79B invested in Ultragenyx Pharmaceutical in 2022 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 90 increasing their positions, 74 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less capital invested
Capital invested by funds: $5.69B → $4.79B (-$893M)
54% less call options, than puts
Call options by funds: $7M | Put options by funds: $15.1M
Holders
238
Holding in Top 10
–
Calls
$7M
Puts
$15.1M
Top Buyers
| 1 | +$34.3M | |
| 2 | +$25M | |
| 3 | +$18.8M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$16M |
| 5 |
O
OrbiMed
New York
|
+$15.8M |
Top Sellers
| 1 | -$141M | |
| 2 | -$35.8M | |
| 3 | -$34.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.93M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.47M |